<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>ijcicr</PublisherName>
<JournalTitle>International Journal of Clinical Investigation and Case Reports</JournalTitle>
<PISSN>C</PISSN>
<EISSN>l</EISSN>
<Volume-Issue>Volume 1, Issue 3</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>Nov-Dec</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>2022</Year>
<Month>12</Month>
<Day>30</Day>
</PubDate>
<ArticleType>Surgery</ArticleType>
<ArticleTitle>Pseudomixoma Peritonei as an Unusual Tumor in a Kidney Donor</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>79</FirstPage>
<LastPage>84</LastPage>
<AuthorList>
<Author>
<FirstName>Alejandro</FirstName>
<LastName>Rossano*</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Bernardo</FirstName>
<LastName>Bravo</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>J. Manuel</FirstName>
<LastName>Portela</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Eduardo</FirstName>
<LastName>Montalvo</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Layla L.</FirstName>
<LastName>Monroy</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Victor</FirstName>
<LastName>Ortiz</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Manuel</FirstName>
<LastName>Lavariega</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Cecilia</FirstName>
<LastName>Gallegos</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Armando López</FirstName>
<LastName>(MEXICO)</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI>10.55828/ijcicr-13-15</DOI>
<Abstract>Introduction: Pseudomixoma peritonei is a neoplasia originating from the appendix, with an incidence of 2-4 per million habitants. Clinical presentation is variable, from asymptomatic to appendicitis, intestinal obstruction, or perforation, and is usually diagnosed incidentally at image studies or by laparoscopy when performing a conventional appendectomy.
Case presentation: 40-year-old male with history of successful left kidney donation developed a pseudomixoma peritonei. At image examination, a CT revealed hypermetabolic activity consistent with peritoneal carcinomatosis, treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy was established with good results and has been followed up for 4 years with no evidence of recurrent disease and adequate kidney function.
Conclusion: Association of appendiceal neoplasms in organ donors has been unusual when developed most common present as carcinomatosis, combined treatment with cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy has shown the best long-term survival for appendiceal neoplasms.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>Pseudomixoma Peritonei,Appendiceal Neoplasm,Carcinomatosis, Kidney Donation,Cytoreductive Surgery,Hyperthermic Intraperitoneal Chemotherapy,Neoplasm in Organ Donor</Keywords>
<URLs>
<Abstract>https://ijcicr.com/ubijournal-v1copy/journals/abstract.php?article_id=14270&title=Pseudomixoma Peritonei as an Unusual Tumor in a Kidney Donor</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>Smeenk RM, Van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34(2):196-201.
Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017;33(5):511-519.
Morera-Ocon FJ, Navarro-Campoy C. History of pseudomyxoma peritonei from its origin to the first decades of the twenty-first century. World J Gastrointest Surg. 2019;11(9):358-364.
Shariff US, Chandrakumaran K, Dayal S, Mohamed F, Cecil TD, Moran BJ. Mode of presentation in 1070 patients with perforated epithelial appendiceal tumors, predominantly with pseudomyxoma peritonei. Dis Colon Rectum. 2020;63(9):1257-1264.
Davison JM, Choudry HA, Pingpank JF, et al. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Modern Pathol. 2014;27(11):1521-1539.
Rizvi SA, Syed W, Shergill R. Approach to pseudomyxoma peritonei. World J Gastrointest Surg. 2018;10(5):49-56.
Engels EA, Fraser GE, Kasiske BL, et al. Cancer risk in living kidney donors. Am J Transplant. 2022;22(8):2006-2015.
Govaerts K, Lurvink RJ, De Hingh IH, et al. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2021;47(1):11-35.
Shaib WL, Assi R, Shamseddine A, et al. Appendiceal mucinous neoplasms: diagnosis and management. Oncol. 2017;22(9):1107-1116.
Kelly KJ. Management of appendix cancer. Clin Colon Rectal Surg. 2015;28(04):247-255.
Videla C, Di Stefano S. Manejo perioperatorio de la cirugand;iacute;a de citorreducciand;oacute;n con quimioterapia intraperitoneal hipertand;eacute;rmica. Rev Argent Terapia Intensiva. 2021;38:e708.16092020.
Lin YL, Xu DZ, Li XB, et al. Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines. Orphanet J Rare Dis. 2021;16(1):1-7.
Harper MM, Kim J, Pandalai PK. Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies. J Clin Med. 2022;11(10):2840.
Carrillo-Esper R, Nava-Land;oacute;pez JA, Romero-Sierra G, Cand;aacute;and;ntilde;ez-Jimand;eacute;nez C. Manejo perioperatorio de la quimioterapia intraperitoneal hipertand;eacute;rmica. Rev Mexi Anestesiol. 2014;37(3):193-200.
Bartlett DJ, Thacker PG, Grotz TE, et al. Mucinous appendiceal neoplasms: classification, imaging, and HIPEC. Abdom Radiol. 2019;44(5):1686-1702.
Van Hooser A, Williams TR, Myers DT. Mucinous appendiceal neoplasms: pathologic classification, clinical implications, imaging spectrum and mimics. Abdom Radiol. 2018;43(11):2913-2922.
Shaib WL, Assi R, Shamseddine A, et al. Appendiceal mucinous neoplasms: diagnosis and management. Oncol. 2017;22(9):1107-1116.
Batista TP, Sarmento BJ, Loureiro JF, et al. A proposal of Brazilian Society of Surgical Oncology (BSSO/SBCO) for standardizing cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma. Revista do Colegio Brasileiro de Cirurgioes. 2017;44:530-544.
Li Y, Zhou YF, Liang H, et al. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol. 2016;22(30):6906.
Bhatt A, Mehta S, Seshadri RA, et al. The initial Indian experience with cytoreductive surgery and HIPEC in the treatment of peritoneal metastases. Indian J Surg Oncol. 2016;7(2):160-165.
Iversen LH, Rasmussen PC, Laurberg S. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. J Br Surg. 2013;100(2):285-292.
Chua TC, Moran BJ, Sugarbaker PH, et al. Early-and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449-2456.
Lentine KL, Vijayan A, Xiao H, et al. Cancer diagnoses after living kidney donation: linking United States registry data and administrative claims. Transplantation. 2012;94(2):139-144.
Smeenk RM, Van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34(2):196-201.</References>
</References>
</Journal>
</Article>
</ArticleSet>